Argentina Cell Reprogramming Market Size & Outlook
Related Markets
Argentina cell reprogramming market highlights
- The Argentina cell reprogramming market generated a revenue of USD 1.4 million in 2024 and is expected to reach USD 2.5 million by 2030.
- The Argentina market is expected to grow at a CAGR of 10.8% from 2025 to 2030.
- In terms of segment, episomal reprogramming was the largest revenue generating technology in 2024.
- MRNA Reprogramming is the most lucrative technology segment registering the fastest growth during the forecast period.
Cell reprogramming market data book summary
| Market revenue in 2024 | USD 1.4 million |
| Market revenue in 2030 | USD 2.5 million |
| Growth rate | 10.8% (CAGR from 2025 to 2030) |
| Largest segment | Episomal reprogramming |
| Fastest growing segment | MRNA Reprogramming |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sendai Virus-based Reprogramming, MRNA Reprogramming, Episomal Reprogramming |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Bio-Techne Corp, ReproCELL, Lonza Group Ltd, FUJIFILM Holdings Corp, Astellas Pharma Inc, Allele Biotech, Alstem, STEMCELL Technologies |
Other key industry trends
- In terms of revenue, Argentina accounted for 0.3% of the global cell reprogramming market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil cell reprogramming market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 2.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Reprogramming Market Scope
Cell Reprogramming Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alstem | View profile | 11-50 | Richmond, Virginia, United States, North America | https://www.alstembio.com/web/ |
| Allele Biotech | View profile | 11-50 | San Diego, California, United States, North America | http://www.allelebiotech.com/ |
| STEMCELL Technologies | View profile | 501-1000 | Vancouver, British Columbia, Canada, North America | https://www.stemcell.com |
| ReproCELL | View profile | 51-100 | Yokohama, Kanagawa, Japan, Asia | http://reprocell.com |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| Bio-Techne Corp | View profile | 3050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | https://www.bio-techne.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Argentina cell reprogramming market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell reprogramming market will help companies and investors design strategic landscapes.
Episomal reprogramming was the largest segment with a revenue share of 35.71% in 2024. Horizon Databook has segmented the Argentina cell reprogramming market based on sendai virus-based reprogramming, mrna reprogramming, episomal reprogramming covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of Parkinsonism being 8.0%, and Parkinson's Disease (PD) being 2.0% in Latin America signifies a substantial health concern. Notably, many PD cases still need to be diagnosed and are unattended, emphasizing the importance of enhancing public health initiatives, especially in regions experiencing accelerated demographic aging and epidemiological shifts.
These insights have been gained from a secondary data analysis from the 10/66 Dementia Research Group, supported by the Well come Trust Health Consequences of Population Change Programme, with Argentina contributing as one of the members. The rising prevalence of such diseases is expected to increase the adoption of cell reprogramming products soon.
Reasons to subscribe to Argentina cell reprogramming market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Argentina cell reprogramming market databook
-
Our clientele includes a mix of cell reprogramming market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina cell reprogramming market , including forecasts for subscribers. This country databook contains high-level insights into Argentina cell reprogramming market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Argentina cell reprogramming market size, by technology, 2018-2030 (US$M)
Argentina Cell Reprogramming Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
